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Once death is imminent, a major concern of the family mem-
bers and caregivers is to assure maximal comfort during this termi-
nal phase. This can often be achieved by ‘‘conventional’’
pharmacological drugs such as opiates or other symptom-control-
ling drugs. However, in case of refractory symptoms leading to
unbearable suffering such as intolerable pain, dyspnea, and delir-
ium, a more drastic option may be chosen, known as palliative
sedation (Table 1). In these cases, comfort is sought by reducing
the patient’s level of consciousness [12,23]. Although palliative
sedation is ethically controversial and some studies have ques-
tioned its efﬁcacy and safety [29], this practice has substantially in-
creased. The incidence of palliative sedation is not easily measured,
partly because there are several deﬁnitions and alternative terms
in use, such as ‘‘terminal sedation’’ and ‘‘continuous sedation until
death,’’ to describe this practice [32]. However, the available stud-
ies indicate that the practice of palliative sedation is increasing in
hospitals, nursing homes, and the home care setting. The overall
reported incidences vary now between 7% and 17% of all deaths
[2,5]. It is assumed that patients who are sedated according to
the current standards of care and the guidelines of palliative seda-
tion are unaware of their clinical situation and therefore do not
experience symptoms of discomfort such as dyspnea, delirium,
and other distressing conditions that are common during the ter-
minal phase. However, a critical evaluation based on more recent
evidence raises the question of whether the current assessments
of suffering and awareness are accurate enough. Our concerns
are based on 3 kinds of problems. Firstly, the assessment of com-
fort in dying patients is challenging; secondly, patients are some-
times mistakenly considered to be unaware; and thirdly, the
titration of drugs is difﬁcult.
2. Problems with assessment of comfort in dying patients
The gold standard for detecting distress is patient self-report-
ing. Several instruments, such as the Visual Analog Scale for Pain,83
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86are based on this. However, in the case of palliative sedation, pa-
tients are usually unable to communicate whether or not they
are still in distress or still (partially) aware of what is happening
around them. Some scales have been developed for noncommuni-
cative patients as well, such as the Critical Care Pain Observational
Tool [18], the Behavioral Pain Scale [1], and the Richmond Agita-
tion-Sedation Scale [3], but several problems have been reported.
A well-documented problem is that these scales cannot detect pain
and awareness in all patients; for example, because they depend
on inferences made from patients’ motor responsiveness [10,33].
Another problem is that these scales have been only partially val-
idated for dying patients and, in most cases, not at all [4,8,31]. In
the guidelines on palliative sedation, it is acknowledged that the
efﬁcacy and safety of palliative sedation is not sufﬁciently under-
stood and that the usefulness of these observational scales has
not been proven [15,16]. These ﬁndings cause even more concern
considering the evidence that family members of patients, com-
pared with caregivers, often have different perceptions of the pa-
tient’s comfort and his/her quality of dying during palliative
sedation. While family members tend to overestimate pain, care-
givers often underestimate it [22]. Furthermore, assessment dis-
crepancy between nurses and physicians often occurs [6,17].
3. Problems with (un)awareness
In recent years, doubts have risen as to whether patients labeled
‘‘unconscious’’ really are completely insensate and unaware. Stud-
ies in different types of patients and settings that critically re-
viewed awareness have consistently reported that persons were,
in contrast to what was assumed by the caregivers, not always
(completely) unaware. For example, several studies showed that
patients diagnosed as being in a vegetative state (now also called
‘‘unresponsive wakefulness syndrome’’) did show some (minimal)
clinical signs of conscious awareness in about 40% of the cases [34].
In some cases, the purportedly unconscious patient could even reli-
ably generate appropriate electroencephalographic responses to 2
distinct commands [14], and occasionally was even able to estab-
lish basic communication with ‘‘yes’’ or ‘‘no’’ answers using func-
tional magnetic resonance imaging [28]. This proved that some
minority of clinically diagnosed unresponsive patients had dis-












































































Core elements in guidelines on palliative sedation.
Indications for palliative sedation
 Refractory symptoms leading to unbearable suffering such as intolerable pain, dyspnea, and delirium [11,12,23,35]
Types of palliative sedation
 Degree: mild, intermediate, and deep [15]
 Continuity: from intermittent to continuous [15]
Ethical principles
 Palliative sedation is normal medical practice and must be clearly distinguished from the termination of life [35]
 Proportionality: the degree of sedation must not be deeper than necessary to relieve suffering [11,12,23,35]
 Palliative sedation will not (usually) hasten death (and that is certainly not the intention) [12,15]
Administration of drugs
 Titration to the minimum of level of consciousness reduction necessary to render symptoms tolerable [16,23,24]
 Lack of consensus
o ‘‘No good evidence exists to strongly recommend one medication over any other of those commonly used in continuous palliative sedation therapy’’ [16]
o ‘‘Midazolam is the drug of ﬁrst choice’’ [24]
Monitoring of palliative sedated patients
 Aspects requiring monitoring: [16]
o Relief of suffering
o Level of consciousness (depth of sedation)
o Adverse side effects of sedation
 Guidelines’ evaluations of the usefulness of monitoring scales
o ‘‘There are no scales available to assess the patient’s comfort during continue sedation’’ [24]
o ‘‘Monitoring (observational) scales exist but the usefulness of these scales has not been proven’’ [16]
o ‘‘Presently no particular scale can be recommended’’ [16,24]
 ‘‘Scales involving administration of painful stimuli are not acceptable’’ [16]
 Frequency of monitoring: every 20 minutes until adequate sedation has been reached and then at least once a day [15,16]
 Nurses have the explicit task to observe, measure, and report [24]
2 R. Deschepper et al. / PAIN

xxx (2013) xxx–xxx
PAIN 8782 No. of Pages 4, Model 5G
26 May 2013awareness that even skilled caregivers were not able to recognize
[25]. Also, patients with locked-in syndrome may be mistakenly
considered unconscious, as may some (rare) patients during gen-
eral anesthesia [19,26]. In contrast to the setting where surgical
or intensive care patients are managed, advanced monitoring
equipment is usually lacking in a palliative or home care setting.
Palliative sedated patients ultimately die and therefore, patient
self-reporting is also missing.
The above ﬁndings show that the ‘‘traditional’’ clinical tools and
procedures to assess comfort and awareness in dying noncommu-
nicative patients have important methodological limitations. It
should be noted that the problems with assessments are not to
be ascribed to lack of competence on the part of the caregivers,
but are of a much more fundamental nature: the absence of reli-
able tools. The developers of guidelines are aware of these limita-
tions and rightly point out that there is a lack of evidence (Table 1).
Some guidelines mention that ‘‘there are no scales available to as-
sess the patient’s comfort’’ [24], and the authors of a recent guide-
line conclude that ‘‘presently no particular scale can be
recommended’’ [16]. Sometimes guidelines refer to sedation scales,
but point out that these scales are ‘‘not intended to measure the ef-
fect of sedation but to make clear when the sedation is too deep’’
[24]. The current guidelines for palliative sedation are therefore
limited to suggesting ‘‘a daily visit by the physician’’ and ‘‘continue
attention to possible expressions of discomfort (eg, facial expres-
sions, movements, etc.)’’ [7,11,24]. Not surprisingly, nurses should
also play an important role in signaling discomfort in sedated pa-
tients [24].
4. Problems with the titration of drugs
Since the aim of palliative sedation is to give optimal comfort
but not to hasten death, the principle of proportionality is a pivotal
aspect of this treatment and hence, the guidelines state that seda-
tion should be ‘‘no deeper than necessary to avoid suffering’’
[9,11,15,16,23,24]. To meet this principle of proportionality, care-
givers should carefully titrate the doses of the drugs so that they
are high enough to provide comfort but should not hasten death.
Studies have shown that palliative sedation does not usually affectPlease cite this article in press as: Deschepper R et al. Palliative sedation: Why
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(2013), http://dx.doi.org/10.1016/j.pain.2013.04.03survival time [27]. However, the fact that palliative sedation is con-
sidered by some to be ‘‘slow euthanasia’’ might lead physicians to
be ‘‘extra careful’’ with the use of high doses of sedative medication
[13]. Several studies have reported underuse of medicines due to a
lack of knowledge, unwarranted beliefs, to avoid the perception of
giving ‘‘excessive’’ doses, and even because of fear among caregiv-
ers of being accused of ‘‘killing’’ the patient [21,30]. In a Dutch
study among nurses, the sedation was considered insufﬁciently
effective by 42% of the respondents [7].
5. How to improve assessments of suffering?
Up until now, studies of the efﬁcacy of palliative sedation to re-
lieve pain and discomfort are based on observational scales or sub-
jective assessments by caregivers [7,29]. Although some efforts
have been made to validate the observation scales, as far as we
know, all these attempts are based on the same paradigm, which
is that all kinds of distress in all patients can be measured by obser-
vation of the patient, and that this is the only available method.
However, in recent years, functional neuroimaging, such as func-
tional magnetic resonance imaging, and encephalography have
proven to be promising technologies for detecting awareness and
pain that cannot be observed or detected by ‘‘traditional’’ methods
[20,28]. Although these technologies also have their limitations
and should not be regarded as a perfect surrogate for self-report,
they provide valuable objective and quantiﬁable indicators of
awareness and pain in noncommunicative patients [20,28]. Strik-
ingly, they have not yet been used to check whether the current
assessments of noncommunicative patients are reliable. It is
remarkable that, given the increasing incidence of palliative seda-
tion, there is so little concern about the risks that patients may
experience an uncomfortable dying phase in which they are unable
to signal their suffering. An assessment tool that would allow clini-
cians to more accurately determine the appropriate doses of med-
ications would also encourage more vigorous symptom
management in the dying.
Paradoxically, the inability to report distress might also be
aggravated or even blocked by the use of drugs that might abolish




























































































































Fig. 1. Triangulation of assessment of distress in the noncommunicative dying
patient. CCPOT, Critical Care Pain Observational Tool; RASS, Richmond Agitation-
Sedation Scale; BPS, Behavioral Pain Scale; fMRI, functional magnetic resonance
imaging; PET, positron emission tomography; ERP, event-related potential; EEG,
electroencephalography; BIS, bispectral index.
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awareness or suffering with very limited, ﬂuctuating or absent
behavioral motor signs of distress [33]. The fact that neuroimaging
or electrophysiology recordings have not been used so far to vali-
date the assessment tools for distress in noncommunicative pa-
tients, even when doubts about these tools have arisen, may be
related to the reluctance in palliative and end-of-life care to bother
patients with high-tech equipment, as in most cases, patients have
already experienced a long treatment period.
Dying uncommunicative patients are a vulnerable population
and therefore, we should do everything possible to assure them a
comfortable death free of pain and distress. We therefore urgently
need a triangulation of methods in which existing observational
scales, subjective assessments of caregivers and family, and neuro-
imaging and/or electrophysiological techniques are combined
(Fig. 1). The latter are noninvasive procedures that should not bur-
den too much the patient and his/her family. Due to the complexity
and the intensity, this integrated mixed method is intended for re-
search and not for everyday clinical assessments. It can be used for
the validation of existing clinical tools for the assessment of dis-
tress in palliative sedated patients. Each of the 3 methods has its
potentials and limitations, but combined they can be used to
achieve the best possible assessments.
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